Annual Current Liabilities
$177.10 M
+$55.07 M+45.13%
December 31, 2023
Summary
- As of February 8, 2025, IMCR annual total current liabilities is $177.10 million, with the most recent change of +$55.07 million (+45.13%) on December 31, 2023.
- During the last 3 years, IMCR annual current liabilities has risen by +$102.15 million (+136.28%).
- IMCR annual current liabilities is now at all-time high.
Performance
IMCR Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$266.25 M
+$81.15 M+43.84%
September 30, 2024
Summary
- As of February 8, 2025, IMCR quarterly total current liabilities is $266.25 million, with the most recent change of +$81.15 million (+43.84%) on September 30, 2024.
- Over the past year, IMCR quarterly current liabilities has increased by +$127.23 million (+91.52%).
- IMCR quarterly current liabilities is now at all-time high.
Performance
IMCR Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
IMCR Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.1% | +91.5% |
| 3 y3 years | +136.3% | +258.4% |
| 5 y5 years | +181.3% | +258.4% |
IMCR Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +114.5% | at high | +281.6% |
| 5 y | 5-year | at high | +136.3% | at high | +335.6% |
| alltime | all time | at high | +181.3% | at high | +335.6% |
Immunocore Holdings Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $266.25 M(+43.8%) |
| Jun 2024 | - | $185.10 M(+19.2%) |
| Mar 2024 | - | $155.29 M(+11.7%) |
| Dec 2023 | $177.10 M(+45.1%) | $139.02 M(+16.7%) |
| Sep 2023 | - | $119.09 M(+2.3%) |
| Jun 2023 | - | $116.40 M(+11.0%) |
| Mar 2023 | - | $104.86 M(+4.0%) |
| Dec 2022 | $122.03 M | $100.83 M(+16.9%) |
| Sep 2022 | - | $86.23 M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $78.30 M(+12.2%) |
| Mar 2022 | - | $69.78 M(-15.5%) |
| Dec 2021 | $82.57 M(+10.2%) | $82.57 M(+11.2%) |
| Sep 2021 | - | $74.28 M(-1.9%) |
| Jun 2021 | - | $75.69 M(+1.1%) |
| Mar 2021 | - | $74.90 M(-0.1%) |
| Dec 2020 | $74.95 M(-32.4%) | $74.95 M(+22.6%) |
| Sep 2020 | - | $61.12 M(-44.8%) |
| Dec 2019 | $110.81 M(+76.0%) | $110.81 M |
| Dec 2018 | $62.95 M | - |
FAQ
- What is Immunocore Holdings annual total current liabilities?
- What is the all time high annual current liabilities for Immunocore Holdings?
- What is Immunocore Holdings annual current liabilities year-on-year change?
- What is Immunocore Holdings quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Immunocore Holdings?
- What is Immunocore Holdings quarterly current liabilities year-on-year change?
What is Immunocore Holdings annual total current liabilities?
The current annual current liabilities of IMCR is $177.10 M
What is the all time high annual current liabilities for Immunocore Holdings?
Immunocore Holdings all-time high annual total current liabilities is $177.10 M
What is Immunocore Holdings annual current liabilities year-on-year change?
Over the past year, IMCR annual total current liabilities has changed by +$55.07 M (+45.13%)
What is Immunocore Holdings quarterly total current liabilities?
The current quarterly current liabilities of IMCR is $266.25 M
What is the all time high quarterly current liabilities for Immunocore Holdings?
Immunocore Holdings all-time high quarterly total current liabilities is $266.25 M
What is Immunocore Holdings quarterly current liabilities year-on-year change?
Over the past year, IMCR quarterly total current liabilities has changed by +$127.23 M (+91.52%)